Blog - Archive for Fraud Investigation

Deputy Attorney General Announces Significant Changes to DOJ Policies Regarding Corporate Investigations and Voluntary Self-Disclosure Incentives

Posted on Fraud Investigation, Health Care Law News October 7, 2022 by Rachel Broughton

On September 15, 2022, Deputy Attorney General Lisa Monaco published a memorandum which laid out the Department of Justice’s (DOJ) new guidelines for policies regarding corporate investigations and voluntary self-disclosures. The DOJ announced it would expand and/or clarify its policies on voluntary self-disclosure, making it its goal to reward companies that have invested in compliance Read more →

Tags :

US DOJ Announces Criminal Charges for $1.2 Billion in Telemedicine, Cardiovascular and Cancer Genetic Testing and DME Fraud

Posted on Fraud Investigation, Health Care Law News July 21, 2022 by Rachel Broughton

On Wednesday, July 20, 2022, the United States Department of Justice (DOJ) announced criminal charges against 36 defendants in 13 federal districts across the United States for more than $1.2 billion in alleged fraudulent telemedicine, cardiovascular and cancer genetic testing, and durable medical equipment (DME) schemes. In connection with the enforcement action, the department seized Read more →

Tags :

Navigating the Broad Implications of EKRA in the Substance Abuse and Diagnostic Laboratory Testing Industries

Posted on Fraud Investigation, Health Care Law News July 19, 2022 by Rachel Broughton

The Eliminating Kickbacks in Recovery Act, otherwise known as EKRA, is a fairly new federal law that targets patient brokering and recovery profiteering. EKRA broadly makes it a federal crime for anyone, with respect to services covered by any health care benefit program, to knowingly and willfully: solicit or receive any remuneration (including any kickback, Read more →

Tags : , , ,

Healthcare Professionals Beware: Genetic Testing Enforcement is On the Rise

Posted on Fraud Investigation, Health Care Law News, Medicare Reimbursement June 17, 2022 by Rachel Broughton

Genetic testing, when medically necessary, can provide physicians with important information for the diagnosis, prevention, and treatment of numerous illnesses. It has become an extremely valuable tool in many fields of medicine and can play a significant role in the overall medical care that a patient receives. In recent years, genetic testing has become heavily Read more →

Tags :

A Glimpse Into AHCA’s Oversight of Fraud, Waste, and Abuse in Florida’s Medicaid Program

Posted on Fraud Investigation, Health Care Law News June 6, 2022 by Rachel Broughton

The Agency for Health Care Administration (AHCA) is the state agency responsible for the licensure and regulation of health care providers in Florida as well as the administration and regulation of the state Medicaid program. Maintaining compliance with AHCA is extremely important for professionals in the healthcare industry and can oftentimes be challenging to navigate Read more →

Tags :